VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
MITTENDORF, ELIZABETH ANN
One or more keywords matched the following items that are connected to
MITTENDORF, ELIZABETH ANN
Item Type
Name
Concept
Cancer Vaccines
Academic Article
Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
Academic Article
Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines.
Academic Article
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Academic Article
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Academic Article
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
Academic Article
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
The GP2 peptide: a HER2/neu-based breast cancer vaccine.
Academic Article
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
Academic Article
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Academic Article
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
Academic Article
Breast cancer vaccines: promise for the future or pipe dream?
Academic Article
Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Academic Article
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37).
Academic Article
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04.
Academic Article
Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.
Academic Article
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
Cancer vaccines: should we be targeting patients with less aggressive disease?
Academic Article
The E75 HER2/neu peptide vaccine.
Academic Article
Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Academic Article
Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?
Academic Article
The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax?) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.
Academic Article
Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.
Academic Article
Cancer vaccines in the new era of cancer immunotherapy.
Academic Article
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
Academic Article
Cancer vaccines in the new era of cancer immunotherapy
Academic Article
HER-2/neu Peptide Breast Cancer Vaccines
Academic Article
Breast Cancer Vaccines
Academic Article
Injecting hope-A review of breast cancer vaccines
Academic Article
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Academic Article
Injecting Hope--A Review of Breast Cancer Vaccines.
Academic Article
The development and use of the E75 (HER2 369-377) peptide vaccine.
Academic Article
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence.
Academic Article
Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+?T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
Academic Article
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
Academic Article
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
Academic Article
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.
Academic Article
Investigation of parameters that determine Nano-DC vaccine transport.
Academic Article
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
Academic Article
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Academic Article
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine.
Academic Article
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
Search Criteria
Cancer Vaccines